Authors:
Motzer, RJ
Rakhit, A
Ginsberg, M
Rittweger, K
Vuky, J
Yu, R
Fettner, S
Hooftman, L
Citation: Rj. Motzer et al., Phase I trial of 40-kd branched pegylated interferon alfa-2a for patients with advanced renal cell carcinoma, J CL ONCOL, 19(5), 2001, pp. 1312-1319
Authors:
Rakhit, A
Yeon, MM
Ferrante, J
Fettner, S
Nadeau, R
Motzer, R
Bukowski, R
Carvajal, DM
Wilkinson, VL
Presky, DH
Magram, J
Gately, MK
Citation: A. Rakhit et al., Down-regulation of the pharmacokinetic-pharmacodynamic response to interleukin-12 during long-term administration to patients with renal cell carcinoma and evaluation of the mechanism of this "adaptive response" in mice, CLIN PHARM, 65(6), 1999, pp. 615-629